ImmuneXcite
researches, discovers, develops and commercializes immune-activating and anti-tumor biotherapeutics for the treatment of cancer... Read moreImmuneXcite
researches, discovers, develops and commercializes immune-activating and anti-tumor biotherapeutics for the treatment of cancer... Read more
News
Nov 30, 2019
BioPortfolio
ImmuneXcite: ImmuneXcite Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14122018 Prices from USD $220
Oct 31, 2018
BioPortfolio
ImmuneXcite: ImmuneXcite Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250
Nov 02, 2017
BioPortfolio
ImmuneXcite: ImmuneXcite Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25102017 Prices from USD $250
Apr 21, 2017
BioPortfolio
ImmuneXcite: ImmuneXcite Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 20032017 Prices from USD $250
Feb 15, 2017
BioPortfolio
ImmuneXcite: ImmuneXcite Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
May 24, 2016
The Business Journals
ImmuneXcite: Lexington cancer biotech ImmuneXcite will move headquarters to Waltham
Apr 02, 2016
PMLiVE
ImmuneXcite: ImmuneXcite boosts senior leadership
Mar 31, 2016
Sonoran Weekly Review
ImmuneXcite: Sanofi SA (ADR) (NYSE:SNY) Backs ImmuneXcite In $8.6 Million Funding Round
Mar 30, 2016
BioSpace
ImmuneXcite: Bay State Startup Bags $8.6 Million, Appoints as CSO and Acting CEO
Mar 30, 2016
FierceBiotechIT
ImmuneXcite: Sanofi-Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round
ImmuneXcite Competitors
1
2
3
4
5
6
7
8
9
10